Employing Neuroimmune Biomarker Assessments to Achieve Earlier & Sensitive Detection of Disease Relevant Pathologies for Patient Stratification & the Development of Therapeutics
- Demonstrating how brain specific disease pathologies can potentially be detected in CSF and blood and how new imaging and molecular techniques could enhance this
- Developing specific tools to monitor neuroimmune markers and showing how they can be employed across neuroinflammatory and neurodegenerative conditions
- Highlighting the importance of early detection through sensitive diagnostic biomarkers, and the ways in which standardized collections and discovery biomarker studies are supporting this.